NEW YORK, March 25, 2026 — Terns Pharmaceuticals (NASDAQ: TERN) is the sharpest premarket mover of Wednesday’s session, climbing approximately 12% to around $55.97 in overnight trading after the Financial Times reported that Merck & Co. (NYSE: MRK) is nearing an approximately $6 billion all-cash acquisition of the clinical-stage oncology biotech. The stock closed Tuesday’s […]